HOME >> MEDICINE >> NEWS
Treating depression important for reducing death after bypass surgery

Authors of a US study in this week's issue of THE LANCET highlight how a substantial proportion of patients undergoing coronary artery bypass surgery are clinically depressed-and that treating depression after surgery could substantially reduce the risk of death among these patients.

Depression is an established risk factor for coronary relapse after bypass surgery; however no previous study has assessed the effect of depression on mortality after bypass surgery.

James Blumenthal from Duke University Medical Center, North Carolina, USA, studied 817 patients undergoing bypass surgery between 1989 and 2001. Patients were assessed for depression before surgery, 6 months after surgery, and were followed-up for up to 12 years.

There were 122 deaths (15%) in an average follow-up of just over five years. Around 40% of patients met the criteria for depression, two-thirds of whom had mild depression, the other third moderate to severe depression. Patients with moderate to severe depression at baseline and those with mild depression sustained from initial to six-month assessment were more than twice as likely to die than patients who were not depressed.

James Blumenthal comments: "These findings have important implications for the management of patients who have undergone coronary artery bypass grafting [CABG]. Despite advances in the medical management of patients after CABG, the prognostic importance of clinical depression provides a further opportunity to reduce adverse outcomes associated with the procedure by treating depressed patients after surgeryWe observed that, after adjustment for other risk factors, depression was associated with a two-to-three-fold increase in risk. Thus, many patients who undergo CABG are at increased risk of death because they are clinically depressed; this risk could be reduced by treatment of depression after surgery. Future studies should investigate the mechanisms responsible for this increased risk and
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
21-Aug-2003


Page: 1 2

Related medicine news :

1. Treating depression helps slow physical decline in older adults, study shows
2. Treating individuals: How generalisable are trial data?
3. Treating blood clots, a half-century later
4. Treating older adults for flu is cost-effective, but preventing it with a yearly flu shot is better
5. Treating acid reflux reduces asthma symptoms and improves quality of life in patients with asthma
6. Treating effects of brain damage
7. Treating eye pain may remove other migraine symptoms
8. New study: Treating depression, low social supports does not reduce heart patients deaths, heart attacks
9. Two Beta-Blocker Drugs Equal In Treating Heart Failure
10. DDW Studies Present Evidence That Thalomid (Thalidomide) Is Active In Treating Crohns Disease
11. Treating Depression Makes A Healthier Heart

Post Your Comments:
(Date:11/22/2014)... 23, 2014 BambooFlooringChina.com is a ... has proudly released its new collection of bamboo mats ... up to 29% off. , According to the ... tree-like grass, making it a highly renewable resource. Their bamboo ... a mixing color which comes from natural bamboo with caramel ...
(Date:11/22/2014)... Setria® Glutathione is now available ... for use “as a therapeutically active ingredient in ... Therapeutic Goods (Listing) Notice 2014 (No. 5) - ... Glutathione will be exclusivity distributed in Australia by ... imports fine chemicals to Australian manufacturers. TGA approval ...
(Date:11/22/2014)... (PRWEB) November 22, 2014 Discount-Dress.com ... aim of the firm is to increase the company’s online ... introduced a new selection of bridesmaid dresses and announced a ... offer is valid until Dec. 30, 2014. All the dresses ... also inexpensive. , In fact, Discount-Dress.com is very good ...
(Date:11/22/2014)... Nocturia is defined by the International ... individual has to wake at night one or ... Pipeline Review, H2 2014” provides comprehensive information on ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ...
(Date:11/22/2014)... A petition seeking a ban on ... in minimally-invasive hysterectomies and fibroid removal surgeries has gained ... October, Bernstein Liebhard LLP reports. According to Change.org, ... 21st, 2014. That represents an increase of 456 signatures ... to the campaign.* , The campaign to ban uterine ...
Breaking Medicine News(10 mins):Health News:Trendy Bamboo Mats Online Now By BambooFlooringChina.com 2Health News:Setria® Glutathione Now Available in Australia 2Health News:Setria® Glutathione Now Available in Australia 3Health News:Bridesmaid Dresses Introduced by Famous Company Discount-Dress.com For The New Year 2015 2Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 2Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 3Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 4Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 4
(Date:11/21/2014)... , Nov. 20, 2014  RedRick Technologies, a ... and reading room environment guidance, has helped the ... radiology reading room, which may also serve as ... Penn Medicine. "In line with ... College of Radiology,s Imaging 3.0 ™ initiative, ...
(Date:11/21/2014)... Calif. , Nov. 20, 2014 Depomed, Inc. (NASDAQ: ... at the Piper Jaffray 26 th Annual Healthcare Conference in ... at the Piper Jaffray conference is scheduled for 8:00 am EST ... be webcast, and the webcast can be accessed via the Investor ... recording of the webcast will be archived for 30 days on ...
(Date:11/21/2014)... Texas , Nov. 21, 2014  Lexicon Pharmaceuticals, ... pricing of its previously announced underwritten public offering of ... an effective shelf registration statement. The offering will consist ... offering price of $1.005 per share.  Lexicon has also ... to 7,462,687 additional shares of common stock.  All of ...
Breaking Medicine Technology:RedRick Technologies Helps Penn Radiology Implement New Radiology Reading Room Concepts 2RedRick Technologies Helps Penn Radiology Implement New Radiology Reading Room Concepts 3Depomed To Present At Piper Jaffray 26th Annual Healthcare Conference 2Lexicon Announces Pricing Of Common Stock Offering 2Lexicon Announces Pricing Of Common Stock Offering 3
Cached News: